Skip to main content

Table 1 Baseline pretreatment laboratory profiles of 86 participants in the initial cross-sectional cohort

From: Changes in inflammatory cytokines, antioxidants and liver stiffness after chelation therapy in individuals with chronic lead poisoning

Parameters

Mean ± SD

Age (years)

37.6 ± 7.3

Waist (cm)

80.2 ± 12.0

BMI (kg/m2)

24.2 ± 4.9

Blood lead level (μg/dL)

81.4 ± 9.8

Hemoglobin (g/dL)

13.4 ± 1.6

White blood cell count (103/μL)

8.0 ± 1.8

Platelets (1012/L)

285.6 ± 58.4

Creatinine (mg/dL)

0.9 ± 0.3

Total bilirubin (mg/dL)

0.8 ± 0.4

Direct bilirubin (mg/dL)

0.3 ± 0.1

Alkaline phosphatase (U/L)

68.8 ± 19.5

SGOT (U/L)

30.7 ± 28.9

SGPT (U/L)

33.3 ± 33.2

Liver stiffness (kPa)

5.4 ± 0.9

CAP (dB/m)

225.1 ± 49.3

  1. Abbreviations: SGOT serum glutamate oxaloacetate transaminase, SGPT serum glutamate pyruvate aminotransferase, CAP controlled attenuation parameters